The data barrage you refer to dismissively is exactly what i and many others have been anxiously waiting for. Positive trial data is priceless to a long. This is the stuff that gets us to the finish line. So while I now have less predicable opportunity to trade around the core, your style of pure catalyst investing is effected quite negatively. 2 very different styles. As a long, the recent changes are most likely only going to provide greater benefits. If I was only riding catalysts, I would be disappointed at suddenly finding myself unable to predict catalyst events. But that doesn't mean they won't happen. To say that the stock is dead in the water until next July is pure supposition and more unlikely than the supposition of newsworthy events in q4,13.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links